Case Report: Recurrent Malignant Struma Ovarii With Hyperthyroidism and Metastases, A Rare Case Report and Review of the Literature

Ruyi Zhang, Xin Tian, Ying Luo, Haiwei Dong, Weijun Tian, Yujie Zhang, Dong Li, Haoran Sun, Zhaowei MengPathology 2022 · DOI

TL;DR

This paper presents a rare case of recurrent malignant struma ovarii (SO) with hyperthyroidism and metastases, highlighting the aggressive nature of this condition. Through a comprehensive literature review, the authors emphasize that malignant SO has a high relapse and metastatic rate, advocating for aggressive surgical and potentially therapeutic interventions.

What Problem Does This Paper Address?

Struma ovarii (SO) is a rare type of ovarian teratoma composed primarily of thyroid tissue. While benign SO is relatively common, malignant SO is exceptionally rare, leading to a scarcity of documented cases and a lack of consensus on its prognosis and optimal management. This paper addresses the challenge of understanding and managing malignant SO, particularly when it presents with recurrent disease, hyperthyroidism, and widespread metastases, which can mimic other conditions and complicate diagnosis and treatment.

Methods

The study employs a two-pronged approach:

  • Case Presentation: A detailed account of a 40-year-old female patient diagnosed with recurrent malignant SO. This includes clinical history, physical examination findings, contrast-enhanced CT imaging, laboratory tests (CA125, thyroglobulin, FT4, TSH), and surgical interventions (liver mass dissection, omentectomy, tumor dissection, peritoneal and rectal nodule resection). Histopathological examination and immunohistochemical staining (Galectin-3, CK19, TTF-1, Ki-67) were crucial for diagnosis.
  • Literature Review: A systematic search of PubMed was conducted using keywords related to SO. A total of 257 eligible articles, encompassing 290 SO cases (114 malignant, 77 benign, and 99 with unknown behavior), were reviewed. Statistical analyses, including Chi-square tests and Kruskal-Wallis tests, were used to compare characteristics between malignant and benign SO.

Datasets

  • Patient Data: The study utilizes data from a single patient diagnosed with recurrent malignant SO.
  • Literature Data: A retrospective analysis of 290 SO cases from 257 published articles formed the basis of the literature review. This dataset was stratified by histological behavior (malignant, benign, unknown).

Key Insights and Ideas

  • Aggressive Nature of Malignant SO: The case and literature review strongly suggest that malignant SO is prone to relapse and metastasis, with a reported metastatic rate of 52.94% in the reviewed cases. This underscores the need for aggressive management strategies.
  • Diagnostic Challenges: Differentiating malignant from benign SO can be difficult, often relying on postoperative histology. Clinical symptoms like abdominal discomfort, bleeding, or urinary compression are not significantly different between the two.
  • Hyperthyroidism as a Mimic: While hyperthyroidism is less common in malignant SO compared to benign SO, its presence can mask the underlying malignancy and lead to misdiagnosis, potentially as Graves' disease.
  • Surgical Considerations: For large tumors that are prone to rupture during laparoscopic surgery, laparotomy may be a safer option to prevent peritoneal seeding.
  • Importance of Immunohistochemistry: Markers like CK19 and TTF-1 can be supportive in diagnosing malignant SO.

Key Results

  • Patient's Case: The 40-year-old patient presented with a large pelvic mass and liver metastasis, diagnosed as malignant SO (papillary type) with hyperthyroidism. Despite aggressive surgical intervention, a recurrent mass was detected six months later.
  • Literature Review Findings:
    • Malignant SO accounted for 59.69% of the reviewed cases, contradicting some previous studies.
  • Malignant SO showed a significantly higher rate of metastasis (52.94%) compared to benign SO (15.38%).
  • Malignant SO cases were more likely to undergo total thyroidectomy and radioactive iodine (RAI) treatment.
  • While CA125 levels were elevated in both groups, they were higher in benign SO. Thyroglobulin (Tg) levels did not show significant differences between the groups.
  • Hyperthyroidism was more prevalent in benign SO (39.02%) than in malignant SO (11.94%).

Limitations and Future Work

  • Limitations:
    • The case report is based on a single patient, limiting generalizability.
  • The literature review's findings are dependent on the quality and completeness of published case reports.
  • In the presented case, a definitive diagnosis of hyperthyroidism was made based on normalization of thyroid hormones post-surgery, but a 123I scan was not performed due to concerns of overdiagnosis.
  • Future Work: The authors suggest that aggressive management, including total hysterectomy, bilateral salpingo-oophorectomy, and total thyroidectomy followed by RAI treatment, should be considered for malignant SO. They also recommend considering laparotomy for large tumors and emphasize the importance of including Graves' disease in the differential diagnosis of hyperthyroidism in patients with SO. Further research is needed to establish clear diagnostic guidelines and optimize treatment strategies for this rare malignancy.

Summary updated

Abstract

<b>Background:</b> SO (Struma ovarii) is a rare form of ovarian teratoma which originates from ovarian dermoid cysts. Due to the rarity of this disease, relevant studies might not be sufficiently documented, especially cases with hyperthyroidism and multiple metastases. <b>Case Presentation:</b> A 40-year-old female patient was admitted to our hospital due to management of early pregnancy along with a recurrent abdominal and pelvic mass. Contrast-enhanced CT images showed an irregular mass (10.7 × 8.6 × 12.8 cm) located in the right side from the hypogastrium to the pelvic cavity and another mass (3.8 × 3.7 cm) in the liver. Laboratory examination showed that CA125 (Carbohydrate Antigen-125) was 118.10 U/mL, Tg (thyroglobulin) was >300 ng/ml, FT4 (free thyroxine) was 22.11 pmol/L, and TSH (thyroid-stimulating hormone) was <0.004 mIU/L. She subsequently underwent liver mass dissection, omentectomy, tumor dissection, peritoneal nodule resection, as well as rectal anterior wall nodule resection. The patient was diagnosed with malignant SO (papillary type) along with multiple metastases. Also, we conducted a literature review based on 290 SO cases from 257 articles. <b>Conclusion:</b> This study showed that malignant SO might be prone to relapse and metastasize (a metastatic rate of 52.94%) and therefore aggressive management might need to be recommended for malignant SO. Also, laparotomy might need to be recommended for large tumors that cannot be resected by laparoscopic surgery since these tumors might be prone to rupture and thus produce peritoneal implants. Furthermore, Graves' disease might need to be considered in the differential diagnosis.
BibTeX
@inproceedings{zhang2022case,
  author = {Ruyi Zhang and Xin Tian and Ying Luo and Haiwei Dong and Weijun Tian and Yujie Zhang and Dong Li and Haoran Sun and Zhaowei Meng},
  title = {{Case Report: Recurrent Malignant Struma Ovarii With Hyperthyroidism and Metastases, A Rare Case Report and Review of the Literature}},
  booktitle = {Pathology},
  year = {2022},
  doi = {10.3389/pore.2022.1610221},
}
Figure